Skip to content

Study on blood pressure management strategy based on cerebral perfusion status after mechanical thrombectomy in acute ischemic stroke

Study on blood pressure management strategy based on cerebral perfusion image after mechanical thrombectomy in acute ischemic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500100416
Enrollment
Unknown
Registered
2025-04-09
Start date
2025-04-30
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Ischemic Stroke

Interventions

Conventional blood pressure management group:Use antihypertensive medications or observation to ensure SBP <=180 mmHg
Perfusion-based blood pressure management group:Use of antihypertensive or vasopressor drugs, a) SBP 120-140 mmHg in hyperperfused patients
b) SBP 140-180 mmHg in hypoperfused patients
c) SBP <=180 mmHg in patients with normal perfusion

Sponsors

Chengdu Second People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with acute ischemic stroke within 24 hours of the onset of the anterior circulation (internal carotid and middle cerebral artery M1/M2) in accordance with mechanical thrombectomy; 2. Age>=18 years; 3. Successful recanalization of blood vessels after MT (mTICI grade reaches 2b: reperfusion 50%-90%; 2c: reperfusion 90%-99%; 3: complete reperfusion); 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients are unlikely to benefit from treatment as judged by the clinician responsible for treatment (e.g., advanced dementia or a high probability of death within 24 hours after endovascular thrombectomy); 2. Has another medical condition that would interfere with outcome assessment and follow-up (e.g., known severe pre-stroke disability, a score of 3-5 on the mRS, advanced cancer, or dialysis due to renal failure); 3. Specific contraindications to any antihypertensive drugs used; 4. Have heart disease such as heart failure (ejection fraction <30%), aortic stenosis or arteriovenous shunt; 5. Pregnant women are lactating; 6. Patients participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Based on 90-day mRS score;

Secondary

MeasureTime frame
ICH Intracranial Hemorrhage;Malignant cerebral hematoma;Three months after surgery, all causes of death, disability, or severe disability;Quality of life 3 months after surgery;

Countries

China

Contacts

Public ContactXin Ding

Chengdu Second People's Hospital

dingxin105@163.com+86 135 6899 2011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026